Alan Messenger, Sales Director at Optimal Industrial Automation, and Manuel Kuhs, Business Development Manager for Europe at Optimal Industrial Technologies, look at the importance of PAT software for Pharma 4.0-oriented data management.
Dr Robin Knight, Co-Founder & Co-CEO of IN-PART, discusses the emerging importance of outsourcing landscaping activities within the pharmaceuticals industry and the benefits of adopting an openly innovative approach that pools sources of innovation.
Dysphagia is a disorder recognised by the WHO and defined as difficulty swallowing solid food and liquids. Carolina Acosta Romero, researcher in mechanochemistry and reactive extrusion, AIMPLAS, discusses easy swallowing solutions for dysphagia.
Roberto Zerbi, global life sciences business development manager at industrial technology manufacturer Watlow, explains the challenge comes that come from developing the EudraLex Volume 4 Annex 1 guidance.
Tunley Engineering are working towards their mission to accelerate decarbonisation globally. Their recent white paper explores the ways in which Synthetic Biology can help Decarbonise Pharmaceuticals.
Nicole Wakes, Senior Director Cell Line Development, and Simon Keen, Vice President Cell Line Development at Abzena, outline the strategies to overcome the challenges of developing BsAbs under increasing pressure for speed.
Developing new drugs is expensive and time-consuming, yet, digital manufacturing techniques are delivering significant benefits without compromising on quality, as Eric Flynn, Head of Pharmaceuticals and Life Sciences at Siemens GB&I explains.
The adoption and implementation of pre-packed process-scale chromatography columns has emerged as a promising solution to improving overall processing efficiency while maintaining high levels of quality and reducing costs.
